Dragging Oncogenes From the Cell: A New Horizon for Targeting KRAS
This Trojan horse-like treatment strategy may help neutralize undruggable cancer drivers.
This Trojan horse-like treatment strategy may help neutralize undruggable cancer drivers.
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
The year 2022 will be remembered as the time when the emergency phase of the COVID-19 pandemic began to...
For the sixth time since 2015, researchers, clinicians, drug developers, patient advocates, and other stakeholders convened at the International...
Factors such as a dense tumor microenvironment, a lack of precise symptoms, and hard-to-target genetic mutations make pancreatic cancer...
“The immuno-oncology revolution is now about 15 years into clinical reality,” said Carl June, MD, FAACR, director of the...
When diagnosed early, lung cancer can often be treated with surgical resection. However, patients with resectable non-small cell lung...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
Each year in the United States, about 14,480 women are diagnosed with cervical cancer, and about 4,290 women die of...
The year 2021 defied our expectations in a variety of ways. The delta and omicron COVID-19 variants imposed unprecedented...